专注于治疗并发症的左前庭塞装置
Cristian Castillo-Rodriguez1, Douglas Salguero2, Diego Cruz1
1From the Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX.
Cardiology in review
|September 5, 2025
概括
左心房塞 (LAAO) 是预防心房动 (AF) 的血液稀释剂的安全替代品. 主要试验证实其与传统抗凝药无劣,严重并发症率低于2%.
科学领域:
- 心脏病学
- 干预心脏病学
- 医疗设备技术
背景情况:
- 前庭动 (AF) 具有显著的中风风险,通常用口服抗凝药治疗.
- 左心房塞 (LAAO) 已成为预防中风的关键替代方案,特别是在高出血风险患者中.
- 了解LAAO的安全性和患者选择对于有效的AF管理至关重要.
研究的目的:
- 审查目前的证据,指示和左心室尾闭塞 (LAAO) 装置的结果.
- 讨论LAAO的患者选择标准,重点关注高出血风险的非膜性AF患者.
- 探索手术安全性,并发症率以及LAAO治疗的未来方向.
主要方法:
- 对LAAO设备的主要临床试验和现有的文献进行系统审查.
- 对手术风险的分析,包括心周溢血,中风和器件栓塞.
- 与华法林和直接口服抗凝剂 (DOACs) 相比,LAAO的疗效评估.
主要成果:
- 在预防中风和全身栓塞方面,LAAO被证明与华法林和DOAC无差别.
- 随着改进的技术,与LAAO手术相关的严重并发症率降至2%以下.
- 理想的候选人包括非膜AF患者,其CHA2DS2- VASc得分高,并且口服抗凝药有禁忌.
结论:
- 在某些心房患者中,LAAO是预防中风的安全有效替代方案.
- 精心选择患者和了解程序风险对于优化LAAO结果至关重要.
- 预计持续的研究和技术进步将进一步扩大LAAO设备在AF管理中的作用.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
160
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
160
Cardiac Catheterization III: Left Heart Catheterization
203
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
203
Aneurysm III: Interprofessional Care
24
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
24
Aortic Regurgitation III: Medical Management
39
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
39
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27


